Literature DB >> 27452435

Comprehensive RNA profiling of villous trophoblast and decidua basalis in pregnancies complicated by preterm birth following intra-amniotic infection.

William E Ackerman1, Irina A Buhimschi2, Haley R Eidem3, David C Rinker4, Antonis Rokas5, Kara Rood6, Guomao Zhao7, Taryn L Summerfield8, Mark B Landon9, Catalin S Buhimschi10.   

Abstract

INTRODUCTION: We performed RNA sequencing with the primary goal of discovering key placental villous trophoblast (VT) and decidua basalis (DB) transcripts differentially expressed in intra-amniotic infection (IAI)-induced preterm birth (PTB).
METHODS: RNA was extracted from 15 paired VT and DB specimens delivered of women with: 1) spontaneous PTB in the setting of amniocentesis-proven IAI and histological chorioamnionitis (n = 5); 2) spontaneous idiopathic PTB (iPTB, n = 5); and 3) physiologic term pregnancy (n = 5). RNA sequencing was performed using the Illumina HiSeq 2500 platform, and a spectrum of computational tools was used for gene prioritization and pathway analyses.
RESULTS: In the VT specimens, 128 unique long transcripts and 7 mature microRNAs differed significantly between pregnancies complicated by IAI relative to iPTB (FDR<0.1). The up-regulated transcripts included many characteristic of myeloblast-derived cells, and bioinformatic analyses revealed enrichment for multiple pathways associated with acute inflammation. In an expanded cohort including additional IAI and iPTB specimens, the expression of three proteins (cathepsin S, lysozyme, and hexokinase 3) and two microRNAs (miR-133a and miR-223) was validated using immunohistochemistry and quantitative PCR, respectively. In the DB specimens, only 11 long transcripts and no microRNAs differed significantly between IAI cases and iPTB controls (FDR<0.1). Comparison of the VT and DB specimens in each clinical scenario revealed signatures distinguishing these placental regions. DISCUSSION: IAI is associated with a transcriptional signature consistent with acute inflammation in the villous trophoblast. The present findings illuminate novel signaling pathways involved in IAI, and suggest putative therapeutic targets and potential biomarkers associated with this condition.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Infection; Placenta; Preterm birth; RNA-sequencing; Transcriptomics; microRNA

Mesh:

Substances:

Year:  2016        PMID: 27452435     DOI: 10.1016/j.placenta.2016.05.010

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.287


  18 in total

1.  Integrated microRNA and mRNA network analysis of the human myometrial transcriptome in the transition from quiescence to labor.

Authors:  William E Ackerman; Irina A Buhimschi; Douglas Brubaker; Sean Maxwell; Kara M Rood; Mark R Chance; Hongwu Jing; Sam Mesiano; Catalin S Buhimschi
Journal:  Biol Reprod       Date:  2018-06-01       Impact factor: 4.285

2.  Toll-like receptor 9, maternal cell-free DNA and myometrial cell response to CpG oligodeoxynucleotide stimulation.

Authors:  Stacy Beck; Irina A Buhimschi; Taryn L Summerfield; William E Ackerman; Ozlem Guzeloglu-Kayisli; Umit A Kayisli; Guomao Zhao; Frederick Schatz; Charles J Lockwood; Catalin S Buhimschi
Journal:  Am J Reprod Immunol       Date:  2019-03-04       Impact factor: 3.886

3.  MiR-133b regulates oxidative stress injury of trophoblasts in preeclampsia by mediating the JAK2/STAT3 signaling pathway.

Authors:  Hai-Yan Yang
Journal:  J Mol Histol       Date:  2021-10-08       Impact factor: 2.611

4.  MiR-133a-3p relieves the oxidative stress induced trophoblast cell apoptosis through the BACH1/Nrf2/HO-1 signaling pathway.

Authors:  H Guo; Y Wang; W Jia; L Liu
Journal:  Physiol Res       Date:  2021-01-14       Impact factor: 1.881

5.  Molecular signatures of labor and nonlabor myometrium with parsimonious classification from 2 calcium transporter genes.

Authors:  William E Ackerman; Catalin S Buhimschi; Ali Snedden; Taryn L Summerfield; Guomao Zhao; Irina A Buhimschi
Journal:  JCI Insight       Date:  2021-06-08

6.  Differential microRNA expression in human placentas of term intra-uterine growth restriction that regulates target genes mediating angiogenesis and amino acid transport.

Authors:  Shanthie Thamotharan; Alison Chu; Katie Kempf; Carla Janzen; Tristan Grogan; David A Elashoff; Sherin U Devaskar
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

7.  Soluble inflammatory mediators induce transcriptional re-organization that is independent of dna methylation changes in cultured human chorionic villous trophoblasts.

Authors:  Kaiyu Jiang; Laiping Wong; Yanmin Chen; Xiaoyun Xing; Daofeng Li; Ting Wang; James N Jarvis
Journal:  J Reprod Immunol       Date:  2018-05-23       Impact factor: 4.054

8.  Enabling precision medicine in neonatology, an integrated repository for preterm birth research.

Authors:  Marina Sirota; Cristel G Thomas; Rebecca Liu; Maya Zuhl; Payal Banerjee; Ronald J Wong; Cecele C Quaintance; Rita Leite; Jessica Chubiz; Rebecca Anderson; Joanne Chappell; Mara Kim; William Grobman; Ge Zhang; Antonis Rokas; Sarah K England; Samuel Parry; Gary M Shaw; Joe Leigh Simpson; Elizabeth Thomson; Atul J Butte
Journal:  Sci Data       Date:  2018-11-06       Impact factor: 6.444

9.  Transcriptomic analysis of equine chorioallantois reveals immune networks and molecular mechanisms involved in nocardioform placentitis.

Authors:  Hossam El-Sheikh Ali; Shavahn C Loux; Laura Kennedy; Kirsten E Scoggin; Pouya Dini; Carleigh E Fedorka; Theodore S Kalbfleisch; Alejandro Esteller-Vico; David W Horohov; Erdal Erol; Craig N Carter; Jackie L Smith; Barry A Ball
Journal:  Vet Res       Date:  2021-07-08       Impact factor: 3.683

10.  integRATE: a desirability-based data integration framework for the prioritization of candidate genes across heterogeneous omics and its application to preterm birth.

Authors:  Haley R Eidem; Jacob L Steenwyk; Jennifer H Wisecaver; John A Capra; Patrick Abbot; Antonis Rokas
Journal:  BMC Med Genomics       Date:  2018-11-19       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.